Q2 2014 13F Holders as of 6/30/2014
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
106M
-
Number of holders
-
60
-
Total 13F shares, excl. options
-
29.7M
-
Shares change
-
-635K
-
Total reported value, excl. options
-
$83.2M
-
Value change
-
-$5.49M
-
Put/Call ratio
-
0
-
Number of buys
-
31
-
Number of sells
-
-28
-
Price
-
$2.80
Significant Holders of CORCEPT THERAPEUTICS INC - Common Stock (CORT) as of Q2 2014
73 filings reported holding CORT - CORCEPT THERAPEUTICS INC - Common Stock as of Q2 2014.
CORCEPT THERAPEUTICS INC - Common Stock (CORT) has 60 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 29.7M shares
of 106M outstanding shares and own 28.05% of the company stock.
Largest 10 shareholders include FEDERATED INVESTORS INC /PA/ (13.3M shares), INVESTOR AB (3.45M shares), BlackRock Institutional Trust Company, N.A. (2.33M shares), VANGUARD GROUP INC (2.15M shares), MORGAN STANLEY (1.5M shares), BlackRock Fund Advisors (1.36M shares), State Street Corp (908K shares), NORTHERN TRUST CORP (606K shares), Catalyst Capital Advisors LLC (540K shares), and GEODE CAPITAL MANAGEMENT, LLC (414K shares).
This table shows the top 60 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.